Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial

AIM: To evaluate the efficacy and safety of mealtime or post‐meal fast‐acting insulin aspart (faster aspart) vs mealtime insulin aspart (IAsp), both in combination with insulin degludec, in participants with type 1 diabetes (T1D). METHODS: This multicentre, treat‐to‐target trial (Clinical trial regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Buse, John B., Carlson, Anders L., Komatsu, Mitsuhisa, Mosenzon, Ofri, Rose, Ludger, Liang, Bo, Buchholtz, Kristine, Horio, Hiroshi, Kadowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231963/
https://www.ncbi.nlm.nih.gov/pubmed/30259644
http://dx.doi.org/10.1111/dom.13545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231963/
https://www.ncbi.nlm.nih.gov/pubmed/30259644
http://dx.doi.org/10.1111/dom.13545

Ejemplares similares